Article
Molecular modelling of novel ADCY3 variant predicts a molecular target for tackling obesity.
International journal of molecular medicine - 1 Jan 2022
Toumba Meropi, Fanis Pavlos, Vlachakis Dimitrios, Neocleous Vassos, Phylactou Leonidas A, Skordis Nicos, Mantzoros Christos S, Pantelidou Maria
Abstract excerpt
Severe early‑onset obesity is mainly attributed to single gene variations of the hypothalamic leptin‑melanocortin system, which is critical for controlling the balance between appetite and energy expenditure. Adenylate cyclase 3 (ADCY3), a transmembrane enzyme localized in primary neuronal cilia, is a key genetic candidate, which appears to have an essential role in regulating body weight. The present study aimed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
